Sign In
Buy AVNS
$24.99
+0 (+0%)
At Close: Jul 31, 2026
Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates
09:25am, Wednesday, 26'th Feb 2025
Avanos Medical (AVNS) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.36 per share a year ago.
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results
07:00am, Wednesday, 26'th Feb 2025
ALPHARETTA, Ga. , Feb. 26, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2024 results.
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results
08:54am, Wednesday, 19'th Feb 2025
ALPHARETTA, Ga. , Feb. 19, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full
Avanos Medical (AVNS) Soars 7.2%: Is Further Upside Left in the Stock?
10:16am, Tuesday, 28'th Jan 2025
Avanos Medical (AVNS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price incre
Reasons to Hold Avanos Medical Stock in Your Portfolio Now
08:50am, Thursday, 23'rd Jan 2025
AVNS' strong product line and focus on R&D raise optimism about the stock.
Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
08:54am, Monday, 06'th Jan 2025
ALPHARETTA, Ga. , Jan. 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will present at the 43rd Annual J.P.
New Strong Sell Stocks for December 11th
04:50am, Wednesday, 11'th Dec 2024
AVNS, BATRK and ELV have been added to the Zacks Rank #5 (Strong Sell) List on December 11, 2024.
Avanos Medical, Inc. to Present at the Stifel 2024 Healthcare Conference
12:07pm, Tuesday, 12'th Nov 2024
ALPHARETTA, Ga. , Nov. 12, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in an analyst-led fireside ch
ALPHARETTA, Ga. , Nov. 11, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has issued its final Medicare Hospital Outpa
Avanos Medical, Inc. to Present at the UBS Healthcare Conference 2024
04:16pm, Friday, 08'th Nov 2024
ALPHARETTA, Ga. , Nov. 8, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in a fireside chat at the UBS
Avanos Medical Launches New CORGRIP® SR
07:00am, Tuesday, 05'th Nov 2024
Advancement to reduce dislodgement in feeding tube retention systems ALPHARETTA, Ga. , Nov. 5, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the launch of its newly designed C
Are Investors Undervaluing Avanos Medical (AVNS) Right Now?
10:45am, Thursday, 31'st Oct 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Avanos Q3 Earnings Meet Estimates, Sales Miss, Gross Margin Contracts
09:46am, Thursday, 31'st Oct 2024
Avanos Medical, Inc. AVNS reported third-quarter 2024 adjusted earnings per share (EPS) from continuing operations of 36 cents, up 20% year over year. The bottom line met the Zacks Consensus Estimate.
Avanos Medical Inc. (AVNS) Q3 2024 Earnings Call Transcript
03:28pm, Wednesday, 30'th Oct 2024
Avanos Medical Inc. (NYSE:AVNS ) Q3 2024 Results Conference Call October 30, 2024 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Gary Blackford - Ch
Avanos Medical (AVNS) Q3 Earnings Meet Estimates
09:01am, Wednesday, 30'th Oct 2024
Avanos Medical (AVNS) came out with quarterly earnings of $0.36 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.30 per share a year ago.
